NEW YORK (TheStreet) -- Herbalife (HLF) rose 7.22% to $69.02, up $4.65 from its previous close of $64.37, at the close of the trading day on Monday after the nutrition company announced fourth-quarter estimates for profits and sales above analysts' predictions.
The company also announced it had increased its share repurchase program by $500 million to $1.5 billion.
Herbalife reported Monday it earned between $1.26 and $1.30 a share, excluding items, for the fourth quarter that ended on Dec. 31. Analysts had expected profit of $1.17 a share, according to Thomson Reuters I/B/E/S. Fourth-quarter sales also rose approximately 19.8%, which equates to approximately $1.27 billion. Analysts had expected $1.22 billion.
The news was not all good, though, as the company forecast first-quarter profit of $1.24 to $1.28 a share and claimed the weak Venezuelan bolivar had hurt its earnings. Analysts expected $1.40 a share.Investor William Ackman also created a new Web site to claim that Herbalife is a pyramid scheme, a belief he has held for quite some time. He claimed on this new site that Herbalife found new distributors through a business that had been convicted in Canada a decade ago of running an illegal pyramid scheme. TheStreet Ratings team rates HERBALIFE LTD as a "buy" with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation: "We rate HERBALIFE LTD (HLF) a BUY. This is driven by several positive factors, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated." Highlights from the analysis by TheStreet Ratings Team goes as follows:
- The revenue growth came in higher than the industry average of 2.5%. Since the same quarter one year prior, revenues rose by 19.3%. Growth in the company's revenue appears to have helped boost the earnings per share.
- Powered by its strong earnings growth of 34.69% and other important driving factors, this stock has surged by 74.62% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the stock's future course, although almost any stock can fall in a broad market decline, HLF should continue to move higher despite the fact that it has already enjoyed a very nice gain in the past year.
- HERBALIFE LTD has improved earnings per share by 34.7% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, HERBALIFE LTD increased its bottom line by earning $3.95 versus $3.32 in the prior year. This year, the market expects an improvement in earnings ($5.25 versus $3.95).
- The net income growth from the same quarter one year ago has exceeded that of the S&P 500 and greatly outperformed compared to the Personal Products industry average. The net income increased by 26.9% when compared to the same quarter one year prior, rising from $111.87 million to $141.95 million.
- The gross profit margin for HERBALIFE LTD is rather high; currently it is at 51.32%. It has increased from the same quarter the previous year. Along with this, the net profit margin of 11.69% is above that of the industry average.
- You can view the full analysis from the report here: HLF Ratings Report
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Check Out Our Best Services for Investors
Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.